Long-term follow up (FU) of patients with durable complete response (DCR) after chemotherapy (CT) and HER2-targeting systemic therapy (HER2-Tx) for HER2+ metastatic breast cancer (MBC).

2014 ◽  
Vol 32 (15_suppl) ◽  
pp. 641-641
Author(s):  
Giuseppe Gullo ◽  
Annamaria De Giorgi ◽  
Cecily Quinn ◽  
Jo Ballot ◽  
Lisa Hammond ◽  
...  
2011 ◽  
Vol 22 (9) ◽  
pp. 933-939 ◽  
Author(s):  
Sandra Geiger ◽  
Jitske Alida Cnossen ◽  
Sophia Horster ◽  
Dorit DiGioia ◽  
Volker Heinemann ◽  
...  

The Breast ◽  
2014 ◽  
Vol 23 (2) ◽  
pp. 165-169 ◽  
Author(s):  
Frederic Fiteni ◽  
Cristian Villanueva ◽  
Fernando Bazan ◽  
Sophie Perrin ◽  
Loic Chaigneau ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document